← Every company
Arcutis Biotherapeutics Inc SEC Filings
What Arcutis Biotherapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ARQT overview →Filings on file
94
since Jan 6, 2020
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 5, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 5, 2026 | Executive or director changeResults announced 8-K | Read ↗ |
| Jul 16, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 9, 2026 | Shareholder vote 8-K | Read ↗ |
| May 6, 2026 | Quarterly report 10-Q | Read ↗ |
| Feb 25, 2026 | Annual report 10-K | Read ↗ |
| Feb 25, 2026 | Results announced 8-K | Read ↗ |
| Dec 8, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 28, 2025 | Quarterly report 10-Q | Read ↗ |
| Oct 28, 2025 | Results announced 8-K | Read ↗ |
| Aug 6, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2025 | Results announced 8-K | Read ↗ |
| Jun 17, 2025 | Shareholder vote 8-K | Read ↗ |
| May 6, 2025 | Quarterly report 10-Q | Read ↗ |
| May 6, 2025 | Results announced 8-K | Read ↗ |
| Apr 10, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 25, 2025 | Annual report 10-K | Read ↗ |
| Feb 25, 2025 | Results announced 8-K | Read ↗ |
| Jan 13, 2025 | Results announced 8-K | Read ↗ |
| Nov 6, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 6, 2024 | Results announced 8-K | Read ↗ |
| Aug 14, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 14, 2024 | Results announced 8-K | Read ↗ |
| Jul 24, 2024 | Quarterly report 10-Q/A | Read ↗ |
| Jun 18, 2024 | Shareholder vote 8-K | Read ↗ |
| May 14, 2024 | Quarterly report 10-Q | Read ↗ |
| May 14, 2024 | Results announced 8-K | Read ↗ |
| Apr 10, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 28, 2024 | Material agreement 8-K | Read ↗ |
| Feb 27, 2024 | Annual report 10-K | Read ↗ |
| Feb 27, 2024 | Results announced 8-K | Read ↗ |
| Feb 15, 2024 | Executive or director change 8-K | Read ↗ |
| Jan 16, 2024 | Tender offer SC TO-I | Read ↗ |
| Nov 3, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 3, 2023 | Results announced 8-K | Read ↗ |
| Oct 19, 2023 | Results announced 8-K | Read ↗ |
| Sep 27, 2023 | Executive or director change 8-K | Read ↗ |
| Sep 15, 2023 | Quarterly report 10-Q/A | Read ↗ |
| Sep 15, 2023 | Quarterly report 10-Q/A | Read ↗ |
| Sep 15, 2023 | Annual report 10-K/A | Read ↗ |
| Sep 7, 2023 | Executive or director change 8-K/A | Read ↗ |
| Aug 18, 2023 | Executive or director change 8-K | Read ↗ |
| Aug 14, 2023 | Material agreement 8-K | Read ↗ |
| Aug 8, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 8, 2023 | Results announced 8-K | Read ↗ |
| Jun 5, 2023 | Shareholder vote 8-K | Read ↗ |
| May 24, 2023 | Executive or director change 8-K | Read ↗ |
| May 9, 2023 | Quarterly report 10-Q | Read ↗ |
| May 9, 2023 | Results announced 8-K | Read ↗ |
| Feb 28, 2023 | Annual report 10-K | Read ↗ |
| Feb 28, 2023 | Results announced 8-K | Read ↗ |
| Nov 8, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 8, 2022 | Results announced 8-K | Read ↗ |
| Sep 7, 2022 | Material agreementNew debt 8-K | Read ↗ |
| Sep 6, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 4, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2022 | Results announced 8-K | Read ↗ |
| Aug 2, 2022 | New debt 8-K | Read ↗ |
| Jun 2, 2022 | Shareholder vote 8-K | Read ↗ |
| May 5, 2022 | Quarterly report 10-Q | Read ↗ |
| May 5, 2022 | Results announced 8-K | Read ↗ |
| Mar 3, 2022 | Annual report 10-K/A | Read ↗ |
| Feb 22, 2022 | Annual report 10-K | Read ↗ |
| Feb 22, 2022 | Results announced 8-K | Read ↗ |
| Dec 23, 2021 | Material agreementNew debt 8-K | Read ↗ |
| Nov 4, 2021 | Quarterly report 10-Q | Read ↗ |
| Nov 4, 2021 | Results announced 8-K | Read ↗ |
| Sep 28, 2021 | Material agreement 8-K | Read ↗ |
| Sep 7, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 5, 2021 | Quarterly report 10-Q | Read ↗ |
| Aug 5, 2021 | Results announced 8-K | Read ↗ |
| Jun 14, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 6, 2021 | Quarterly report 10-Q | Read ↗ |
| May 4, 2021 | Results announced 8-K | Read ↗ |
| Mar 26, 2021 | Executive or director change 8-K | Read ↗ |
| Feb 16, 2021 | Annual report 10-K | Read ↗ |
| Feb 16, 2021 | Results announced 8-K | Read ↗ |
| Feb 5, 2021 | Results announced 8-K | Read ↗ |
| Jan 15, 2021 | Material agreement 8-K | Read ↗ |
| Nov 5, 2020 | Quarterly report 10-Q | Read ↗ |
| Nov 5, 2020 | Results announced 8-K | Read ↗ |
| Nov 4, 2020 | Executive or director change 8-K | Read ↗ |
| Oct 6, 2020 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Oct 5, 2020 | Share offering 424B4 | Read ↗ |
| Sep 29, 2020 | Share offering S-1 | Read ↗ |
| Aug 11, 2020 | Quarterly report 10-Q | Read ↗ |
| Jul 29, 2020 | Executive or director change 8-K | Read ↗ |
| May 13, 2020 | Results announced 8-K | Read ↗ |
| May 12, 2020 | Quarterly report 10-Q | Read ↗ |
| Apr 29, 2020 | Material agreement 8-K | Read ↗ |
| Apr 27, 2020 | Executive or director change 8-K | Read ↗ |
| Mar 19, 2020 | Annual report 10-K | Read ↗ |
| Jan 31, 2020 | Share offering 424B4 | Read ↗ |
| Jan 6, 2020 | Share offering S-1 | Read ↗ |
Source: Arcutis Biotherapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ARQT
Company overviewEverything on ARQT in one place, with the price.Insider tradingWhat ARQT's own officers and directors buy and sell.Planned salesSales ARQT insiders have filed notice of.Executive payWhat ARQT awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ARQT.Funds holding itWhich funds and ETFs hold ARQT, and how big a bet.LobbyingWhat ARQT spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ARQT's account, and who they worked for.PatentsWhat ARQT is filing at the patent office.